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ABSTRACT: This report examines the experiences of five provider organizations in developing, 
testing, and implementing quality-of-care indicators, based on data collected from their electronic 
health record (EHR) systems. HealthPartners used the EHR to compile blood pressure 
measurements, Park Nicollet Health Services developed a composite measure for care of people 
with diabetes, Billings Clinic tested an automatic alert on potential interactions between 
antibiotics and the anticoagulant warfarin, Kaiser Permanente used a natural-language processing 
tool for counseling about tobacco use, and Geisinger Health System explored ways of reconciling 
Problem Lists and provider-visit notes regarding high-impact chronic-disease diagnoses. 
Common themes emerged from these case studies. They included challenges—of ensuring the 
validity and reliability of data, efficient workflow, and staff support—but the providers’ successes 
in implementing their respective EHR-based quality measures demonstrated that such measures 
are adaptable to different EHR systems, amenable to improvement, and worth pursuing. 
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 EXECUTIVE SUMMARY 
 
 
The emergence of the electronic health record (EHR), also termed the electronic 
medical record, has made new indicators of quality and safety both necessary and feasible. 
By developing appropriate indicators now, we can integrate them into evolving EHR 
systems early on rather than try to add them after the fact—a much more difficult task. 
This report examines the experiences of five provider organizations in developing, testing, 
and implementing such indicators, based on data collected from their EHR systems. 
 
To set the stage, we developed a typology for categorizing electronic measures 
(“e-indicators”) of quality and safety, with special reference to ambulatory care. The 
five categories are: 
 
1. Translational e-indicators are measures that have been translated from 
existing—“traditional”—measurement sets (e.g., HEDIS or NQF standard 
measures) for use in health information technology (HIT) platforms. 
2. HIT-facilitated e-indicators are measures that, while not conceptually limited to 
HIT-derived data sources, would not be operationally feasible in settings without 
HIT platforms. Measuring clinical physiologic outcomes on 100 percent of 
patients, for instance, would not be amenable to traditional systems. 
3. HIT-enabled e-indicators are innovative measures that would not generally be 
possible outside of the HIT context. These indicators are linked to unique HIT 
capabilities such as computerized provider order entry (CPOE), clinical decision 
support systems (CDSS), biometric devices, or Web-based patient portals. 
4. HIT-system-management e-indicators are measures needed to implement, 
manage, evaluate, and generally improve HIT systems. They are primarily 
intended for use by the parent organization. 
5. “E-iatrogenesis” e-indicators are measures of patient harm caused at least in 
part by the application of health information technology. They assess the degree 
to which unanticipated quality and safety problems arise, whether of human 
(provider or patient), technical, or organizational/system origin. 
 
The case studies presented in this report illustrate the use of the first four categories 
of e-indicators. The HealthPartners case study analyzed the potential of EHRs to compute 
traditional quality measures (in this case, blood pressure control) aimed at reducing the 
time and cost required to assemble the data. The Park Nicollet Health Services case 
 vi
 study illustrated the power of the EHR to assemble composite measures (in this case, 
diabetes) that are theoretically possible without an EHR but infeasible in practice. The 
Billings Clinic case study exemplified the HIT strengths of EHRs to coordinate care and 
measure its outcomes, in this case for a warfarin/antibiotic alert tied to a warfarin clinic. 
The Kaiser Permanente of the Northwest case study overcame the “free-text 
dilemma”—that free text, or unstructured information, cannot be readily used for 
quantitative analyses—by using natural language processing to capture information in 
text notes. Work at Geisinger Health System, meanwhile, focused on reconciling 
information on the health problem list (a structured-text field) with information in the 
visit note (an unstructured-text field). 
 
From these case studies, a number of common themes emerged: 
 
• It is striking how much more clinically relevant measures can become when they 
are HIT-based. For example, a composite measure reflects a more complete clinical 
picture of a person with diabetes than a single component of the measure can. 
• A major barrier in conceptualizing and developing the e-indicators was the 
validity of EHR-extracted data, which critically depends on use of the correct 
patient population. If patients are incorrectly included in or excluded from a 
measure, the quality measures will be inaccurate. 
• Another major barrier was the sometimes questionable reliability of EHR-
extracted data, particularly when their collection and recording were inconsistent; 
the case studies suggested that it was difficult to consistently code data about 
patients, diagnoses, and procedures. But in addition to identifying these accuracy 
concerns, most of the case studies implemented workable solutions. 
• Prior to implementation of the measures, providers expressed concern that EHRs 
would hinder workflow or suffer from staff resistance. Surprisingly, these issues 
did not present themselves. To the contrary, the case studies indicated that EHR 
systems enhanced workflow by automating key communications between staff 
and improving patient-record accessibility across different clinics. 
• Measures that translated established quality indicators had the easiest transition 
into EHR implementation. Measures incorporating or evaluating HIT-specific 
features, such as automated alerts and free-text analysis, tended to be specialized 
to particular systems and not so easily incorporated into other systems. 
Nonetheless, most of the providers were confident that the concepts could be 
adapted to different EHR system types and that virtually all of the problems 
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 encountered were amenable to performance improvement—often made possible 
by the EHR. 
 
The success of these providers in implementing EHR-based quality measures 
demonstrates that such measures are worth pursuing, despite the challenges of ensuring 
the validity and reliability of data, efficient workflow, and staff support. 
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 PERFORMANCE MEASURES 
USING ELECTRONIC HEALTH RECORDS: 
FIVE CASE STUDIES 
 
 
INTRODUCTION 
 
 
Electronic health records (EHRs), also termed electronic medical records, are not 
yet widespread in the United States, though several leading provider organizations have 
begun to deploy them, and they are widely considered the wave of the future. EHRs and 
related health information technology (HIT)—such as computerized physician order 
entry (CPOE), clinical decision support systems (CDSS), and Web-based patient 
portals—significantly enhance our ability to evaluate the processes and outcomes of 
health care and the degree to which consumer needs are being met. But these and other 
traits of EHRs call for new indicators of quality and safety. By developing appropriate 
indicators now, we can integrate them into evolving EHR systems early on rather than try 
to add them after the fact—a much more difficult task. 
 
This report examines the experiences of five provider organizations in 
developing, testing, and implementing quality-of-care indicators, based on data collected 
from their EHR systems. While the focus of each case study was unique, they presented 
common strengths and weaknesses. 
 
EHR systems should have the following features: 
 
• Accuracy (validity). Data derived from patient records, both inside and outside the 
system, must be correct and complete. 
• Standardization (reliability). Information taken from each patient must be 
standard and consistent, both across the subject population and within individual 
patient records. 
• Generalizability. Measures should be able to be translated effectively between 
different data-collection systems. 
• Workflow efficiency. Data collection should be structured as part of the work 
process to avoid negatively affecting patient visits—and ideally, to make visits 
more efficient. 
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 • Staff support. Management and staff should together develop an infrastructure 
that encourages support of and adherence to the quality-measurement program. 
 
These characteristics embrace the continuum of issues encountered—technical 
issues (such as validity, reliability, generalizability), human-technology interface issues 
(workflow efficiency), and cultural issues (staff support)—when using EHRs to support 
quality measurement. 
 
Quality indicators have traditionally been developed by organizations such as the 
National Committee on Quality Assurance and the American Medical Association’s 
Physician Consortium for Performance Improvement. Developed measures have been 
approved for use by organizations such as the National Quality Forum and the Joint 
Commission for the Accreditation of Healthcare Organizations. Still other organizations, 
such as the Ambulatory Quality Alliance, Bridges to Excellence, and Medicare, are 
primarily responsible for implementing the measures. 
 
These indicators traditionally depend on information derived from insurance 
claims (or other billing data), medical records, and quality-of-care surveys of patients. As 
many leading provider organizations have implemented large EHR systems, quality 
information has also increasingly come from the EHRs themselves. 
 
EHRs and related HIT components offer many opportunities for organizations 
wishing to dramatically expand their quality- and safety-improvement activities or other 
types of performance monitoring. However, because the deployment of EHRs can also 
have some negative consequences, a number of related quality challenges are beginning 
to emerge. Often, they arise during the transition from manual to electronic systems (Ash 
2004, Bates 2001, Berger 2004). But even after a system has become functional, 
problems can persist (Koppel 2005). 
 
We have developed a typology for categorizing the broad types of electronic 
indicators (“e-indicators”) of quality and safety, with special reference to ambulatory 
care. It was based on our understanding of how interoperable EHRs and other types of 
HIT have been used to date, as well as on the potential that we, the members of our 
provider consortium, and the early adopters we interviewed envision they may have 
before long. 
 
This typology is not meant to replace other ways of thinking about quality—for 
example, the Institute of Medicine’s six attributes of quality (safe, effective, patient-
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 centered, timely, efficient, and equitable) or Donabedian’s triumvirate of structure, 
process, and outcome. A new typology of e-indicators is necessary, given the functions 
and capabilities not seen before and the system-induced problems that have emerged, and 
we believe the typology can be used as an adjunct. In that way, it can help us 
communicate with one another as HIT-based quality improvement and monitoring 
systems are developed, implemented, and evaluated. 
 
The five-class typology of electronic indicators we propose is as follows: 
 
1. Translational e-indicators are measures that have been translated from 
existing—“traditional”—measurement sets (e.g., HEDIS or NQF standard 
measures) for use in HIT platforms. 
Examples of translational measures include, for example, the number of 
patients with diabetes having an eye-care referral or the number of children 
receiving appropriate immunizations. Issues that surround the comparability of 
such translational measures have been the subject of a number of recent papers 
(Tang 2007). 
If a traditional paper-chart-derived measure (e.g., blood-pressure readings 
or actual laboratory values) is expanded from a limited subsample of patients to a 
full patient population, it should be considered an “HIT-facilitated” measure (see 
below) rather than a translational measure. 
2. HIT-facilitated e-indicators are measures that, while not conceptually limited to 
HIT-derived data sources, would not be operationally feasible in settings without 
HIT platforms. 
Examples of HIT-facilitated measure include: clinical outcomes of 100 
percent of patients based on physiologic measures such as Body Mass Index, 
blood pressure, or laboratory values; percentage of cases in which clinicians or 
patients receive reminders for preventive screening; and percentage of newly 
written prescriptions that are filled by the patient within seven days. 
3. HIT-enabled e-indicators are innovative measures that would not generally be 
possible outside of the HIT context. These indicators, linked to unique HIT 
capabilities such as CPOE, CDSS, biometric devices, or Web-based patient portals, 
may involve only one HIT component or require the interaction of several. 
Examples of HIT-enabled measures include: percentage of patients for 
whom real-time CDSS modules have been appropriately applied in support of the 
diagnostic process; percentage of congestive-heart-failure patients with daily 
e-monitored weight gain greater than x pounds, acted upon by the responsible 
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 clinician within y hours; percentage of patients who respond appropriately to 
messages regarding abnormal test results; percentage of generalists who view the 
medical notes added by a consulting specialist within seven days of the consult; 
and percentage of overweight adults referred to nutrition class through a CPOE. 
4. HIT-system-management e-indicators are measures needed to implement, 
manage, evaluate, and generally improve HIT systems, and they are primarily 
intended for use by the parent organization. However, these measures can also be 
used by an external body (e.g., a payer) to evaluate the organization and the HIT 
system it deploys for the consumer population of interest. 
Examples of HIT-system-management measures include: EHR  
item-completion rates; attainment of community interoperability targets; a 
 CDSS algorithm’s accuracy; percentage of real-time alerts bypassed by the 
clinician; percentage of patient-allergy lists reviewed by patients (via Web portal) 
annually; and ease of access of measures that are maintained in the free-text 
section of the EHR. 
5. “E-iatrogenesis” e-indicators are measures of patient harm caused at least in 
part by the application of health information technology. They assess the 
 degree to which unanticipated quality and safety problems arise, whether of 
human (provider or patient), technological, or organizational/system origin, and 
they may involve errors of commission or omission (Ash 2004, Campbell 2006, 
Weiner 2007). 
Examples of e-iatrogenesis measures include: percentage of patients 
receiving incorrect medications or procedures because of HIT-related errors in the 
CPOE process; percentage of patients experiencing a degree of harm from an 
unanticipated care-delivery event; percentage of significant CDSS errors (either 
type 1 or type 2) for a particular condition; human/machine interaction errors that 
lead to an incorrectly entered diagnosis; and the number of patients experiencing 
harm because they received another patient’s orders by CPOE. 
This measure is designated separately because of its key importance to 
those concerned with quality and safety in the HIT context. 
 
The case studies of this report illustrate the use of the first four categories of e-
indicators: translational (HealthPartners), HIT-facilitated (Park Nicollet), HIT-enabled 
(Billings Clinic), and HIT-system-management (Geisinger, Kaiser-Portland). 
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 • The HealthPartners case study analyzed the potential of EHRs to compute 
traditional quality measures (in this case, blood pressure control) aimed at 
reducing the time needed to assemble the data. 
• The Park Nicollet case study illustrated the power of EHRs to assemble composite 
measures (in this case, diabetes) that are theoretically possible without an EHR 
but infeasible in practice. 
• The Billings Clinic case study exemplified the HIT strengths of EHRs to 
coordinate care and measure its outcomes, in this case for a warfarin/antibiotic 
alert tied to a warfarin clinic. 
• The Kaiser-Portland case study overcame the “free-text dilemma”—that free text, 
or unstructured information, cannot be readily used for quantitative analyses. 
They used natural-language processing, in this case for counseling about tobacco 
use, to capture information in text notes. 
• Work at Geisinger focused on reconciling information on the health-problem list 
(a structured-text field) with information in the visit note (an unstructured-text field). 
 
These case studies, involving five leading provider organizations, highlighted 
the variety, strengths, and potential challenges of quality indicators associated with EHR 
data. Although the particulars of each case study were different, the cases presented many 
common benefits and barriers. Thus, the overall lessons from these providers’ experiences 
can help guide future efforts to integrate quality measurement into EHR systems. 
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 CASE STUDY #1 
Using the EHR to Compile Blood Pressure Measurements 
 
HealthPartners 
Minneapolis, Minnesota 
 
James T. Krizak, Shadi Awwad, and Lynne Dancha 
 
 
Introduction 
 Hypertension 
Controlling high blood pressure (CBP), an important clinical outcome, is now a quality-
of-care measure adopted by the National Committee for Quality Assurance (NCQA) for 
the Health Plan Employer Data and Information Set (HEDIS). NCQA added this measure 
to its core measurements because hypertension has been a challenge for providers to 
control—through the mid-1990s, only 27.4 percent of patients with hypertension had 
their blood pressure under control. Because CBP is included in HEDIS accreditation 
measures, health plans are focusing more attention on improving this rate. 
 
CBP has also been adopted by Minnesota Community Measurement, a nonprofit 
entity whose mission is to accelerate the improvement of health by publicly reporting 
health care information. While NCQA publishes HEDIS measurement results for 
numerous national health plans, Minnesota Community Measurement publishes quality 
results for medical groups in Minnesota. 
 
HealthPartners 
HealthPartners is the largest consumer-governed nonprofit health care organization in the 
nation; with 635,000 members, a full-service hospital, more than 50 clinical sites, and 
nearly 580 practicing physicians. 
 
HealthPartners’ own Medical Group, which treats some 40 percent of the health 
plan’s members, fully converted to electronic health records (using the EPIC system) by 
January 2005. While other medical groups that treat members of HealthPartners have also 
converted to electronic health records, HealthPartners currently does not have access to 
their data. Thus our study population represented only 40 percent of the people enrolled 
in the health plan. 
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 HealthPartners has played major leadership roles in the development both of 
HEDIS and Minnesota Community Measurement®. While it is now producing numerous 
quality measures using EHR data—such as for asthma, depression, diabetes, 
hypertension, children’s health, and adult preventive services—this case study focused on 
the CBP measure. 
 
Goal 
By following HEDIS specifications, a health plan is assured that its results will be 
accepted by NCQA and also that the results can figure in comparisons with other 
providers that use HEDIS specifications. Within NCQA’s Quality Compass grade 
system, there are five bands for any HEDIS measure, corresponding to a health plan’s 
compliance percentage rate. After achieving certain band grades, a health plan may 
receive accreditation from NCQA, thereby greatly increasing its credibility in the 
community. Because blood pressure control is a key indicator among HEDIS 
measurements, it is a prerequisite to accreditation, and, to gain that status, 
HealthPartners’ goal is to reach CBP’s highest band. 
 
Sample 
HEDIS guidelines require that the population used for CBP include only patients who are 
46-85 years old as of December 31 of the measurement year. A subject is considered to 
have hypertension if there is at least one outpatient encounter, verified by chart review, 
with an ICD-9 (International Classification of Disease version 9) code of 401 (Essential 
Hypertension) during the first six months of the measurement year. The patient’s blood 
pressure is considered to be under control when his or her reading is less than or equal to 
140/90. 
 
Measurement 
The actual measurement is the percentage of hypertensive patients satisfying the criteria 
of the above paragraph. Historically, collection of data for the CBP measure required an 
electronic scan of administrative claims data for an ICD-9 diagnosis code of 
hypertension, followed by a manual review of the identified patients’ medical records to 
verify diagnosis and record systolic and diastolic blood pressure readings. 
 
In this case study, HealthPartners followed the HEDIS specifications for the CBP 
measure—which dictate the minimum size of the random sample—in order to determine 
the measurement population. The health plan then increased the sample size by 10 
percent to allow for diagnostic coding issues on claims data (occasionally, patients 
without hypertension or with an inappropriate age are identified and need to be removed 
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 from the sample). For 2005 dates of service, HealthPartners’ sample for the blood 
pressure measure was 1,121 patients, identified by looking for a diagnosis of 
hypertension among claims data. 
 
NCQA requires that the hypertension diagnosis be verified by chart review, so 
HealthPartners adapted the EHR to do this verification. An electronic scan of structured 
analytic fields in HealthPartners EHR data found that 464 patients (41%) in the sample 
population had a substantiated diagnosis of hypertension and a subsequent blood pressure 
reading less than or equal to 140/90. The remaining 657 patients required a manual 
review of patient medical records to substantiate the diagnosis of hypertension or to find 
that blood pressure was under control. These 657 patients either were not HealthPartners 
Medical Group patients (so they had no HealthPartners’ EHR) or they were 
HealthPartners members whose blood pressure was not under control. 
 
A benefit of using EHR data was elimination of the need for manual review of 
464 patient medical records, which saved HealthPartners about $5,500 (based on a 
calculated average cost of $12.00 per record to review). Although such savings per 
individual are small, when applied over a large population of patients—and especially 
when combined with other indicators that use EHR data to achieve standard levels—the 
savings add up. 
 
Verification and Reliability 
Using EHR databases in the data warehouse, 464 patients were identified as having 
hypertension but having their blood pressure under control. To test the data’s reliability, 
we examined the records of a random sample of these patients. Individual records were 
manually reviewed, using the EHR’s front end—the section that auditors use to confirm 
the diagnosis or find the current blood pressure. Similarly, the date of the most recent 
blood pressure test and the blood pressure levels recorded from the EHR database were 
verified. This test was repeated three times because the first and second reviews 
uncovered errors in the logic that inappropriately contradicted the EHR warehouse. After 
correcting the logic, a 100 percent match was achieved between records retrieved from 
the warehouse and the way they appeared in the EHR front end. 
 
Results 
HEDIS guidelines have been followed since 2000, with results showing a positive trend 
in the CBP measure, as shown in the table. The rate represents the percentage of 
commercial members identified as having both hypertension and their blood pressure 
under control (≤140/90). 
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 In HEDIS year 2006, HealthPartners was 0.8 percent away from achieving  
Band 1—the highest rank in the NCQA ratings, representing the 90th percentile of all 
HEDIS managed care organizations. The best practice of providers for the CBP measure 
was CIGNA HealthCare of Colorado, Inc., at 83.7 percent. 
 
Between 2002 and 2003, there was a large jump in the CBP rate, which analysis 
correlated with HealthPartners’ full implementation of its EHR system. During that 
period the number of EPIC (warehouse that stores EHR data) members increased by 75.8 
percent and the number of blood-pressure readings taken from members and stored in 
EPIC went up 186.7 percent. The table shows these variables’ values from services years 
2000 to 2006. 
 
Possible inferences from these data: 
 
• Implementation of the EHR results in better documentation, which then leads to 
an increase in people with hypertension having their blood pressure taken, 
recorded, and managed, which can then lead to more patients being in control. 
 
• The EHR certainly makes it much easier to find data. Before, auditors had to 
manually chase down a patient’s data, with the possibility of never finding what 
they were looking for. Now, a query can be done against the EPIC warehouse, 
and all blood pressures are identified, no matter which HealthPartners clinic was 
visited. This ready availability of data can lead to a better compliance rate. 
 
Challenges 
When EHR data were accessed for the first time to report CBP, lack of familiarity with 
the new warehouse made finding the needed data elements difficult to achieve. EHR 
extracts were pulled from EPIC and reviewed to verify that the correct codes were being 
used for the hypertension confirmation and that the blood pressure readings were 
complete. Still, because review of the EPIC warehouse is an ongoing process, accurate 
results cannot yet be guaranteed. 
 
Conclusions 
The hopes for this movement to EHR are to eliminate the time and cost of pulling data 
manually and to make the results more robust. When using EHR data, multiple 
indicators—such as blood pressure, LDL, HDL, HBA1c, BMI, immunization history, and 
smoking status—can be pulled and reviewed simultaneously. Also, it seems that with the 
implementation of an EHR system, HEDIS compliance rates may actually increase, as 
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 they appear to do for the Controlling High Blood Pressure measure (see figure below). 
(The apparent drop in performance in 2006 was, in fact, due to a HEDIS specification 
change. The requirement for being under control went from <140/90 to <140/90, 
resulting in a surprising impact on this measure’s rates.) 
 
Figure 1.  HealthPartners EMR Data in Contrast with 
HEDIS Controlling High Blood Pressure Results
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Notes: The 2006 Controlling High Blood Pressure (CBP) rate dropped because of 
HEDIS specification changes. The requirement for being under control went from 
<140/90 to <140/90. 
 
Although further investigation is needed, the use of EHR data has the potential to 
increase the quality of care. Not only did HealthPartners’ rate for CBP increase through 
the years, its National Band performance improved as well. This is illustrated in the table 
below (a lower band is better). 
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 Table 1. Results for Electronic Health Records (EHRs) 
and Blood Pressure (BP) Readings 
HEDIS 
Measurement 
Year 
Service 
Year 
Number of 
Members 
with EHR 
Number of 
BP Readings in 
EPIC Warehouse 
HEDIS Results 
for Controlling 
High BP Measure 
HEDIS 
Band 
2001 2000 12,493 26,209 56.8% 3 
2002 2001 16,030 37,350 56.8% 4 
2003 2002 110,940 214,295 65.9% 2 
2004 2003 195,031 614,373 65.9% 3 
2005 2004 191,158 609,786 71.5% 3 
2006 2005 197,220 618,468 75.4% 2 
2007 2006 206,548 631,495 67.4% 2 
Note: Results for 2006 are the number of EPIC members and BP readings as of 12/18/2006. 
 
Finally, it must be noted that the methods employed in calculating the CBP 
measure were reviewed and approved by an independent auditor, in accordance with 
NCQA/HEDIS specifications. 
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 CASE STUDY #2 
Optimal Care for Diabetes: Linking Measurement with Improvement 
 
Park Nicollet Health Services 
Minneapolis, Minnesota 
 
Nancy Jarvis, M.D., and Shadi Awwad, M.S. 
 
 
This case study describes the definition, evolution, and use of a composite measure for 
care of people with diabetes in a clinical setting. 
 
Description of the Study Site 
Park Nicollet Health Services—an integrated care system consisting of Park Nicollet 
Clinic, Park Nicollet Methodist Hospital, Park Nicollet Foundation, and Park Nicollet 
Institute—in 2003 completed development of a $60-million health information 
infrastructure that features a comprehensive electronic health record spanning the hospital 
and all clinical locations. The vendor for this system is GE Centricity (formerly IDX). 
The organization’s EHR/HIT support includes a single ambulatory/inpatient/home care 
medical record, a multifaceted clinical decision support system, electronic reminders for 
patients and clinicians, laboratory/radiology results management, provider/patient 
communications networks, and computerized physician order entry for the hospital. 
 
Park Nicollet Clinic is one of the largest multispecialty clinics in the United 
States, providing care in 45 medical specialties and subspecialties. Almost 8,000 
employees, including 690 physicians and 270 clinical professionals, are on staff at 25 
clinics in Minneapolis and its surrounding suburbs. Park Nicollet Clinic provides care for 
patients with diabetes through its primary care departments (family medicine and internal 
medicine), adult endocrine and pediatric endocrine departments, and International 
Diabetes Center, which provides education for diabetes patients and their families. 
 
Brief Description of the Composite All-or-None Measure 
The composite measure is the percent of diabetes patients age 18 through 75 who have 
achieved hemoglobin A1c <7, LDL cholesterol <100, and blood pressure <130/80; take 
aspirin daily; and do not use tobacco. 
 
This composite measure is calculated monthly at three levels: (1) individual 
clinician, (2) site (and department within site, if appropriate), and (3) overall care system. 
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 Rationale for the Measure 
In the United States, nearly 21 million people have diabetes. It is a fast-growing epidemic 
with enormous quality-of-life and public health implications and rapidly increasing health 
care costs. The above five components of the composite measure were chosen because 
they are representative of what many organizations, large and small, are using as quality 
indicators for individuals with diabetes. Attention to this condition is further driven by 
pay-for-performance and public-reporting initiatives, leading many institutions to choose 
diabetes as one of the earliest opportunities for management of populations of patients 
quality improvement, and measurement. 
 
Composite All-or-None Measures 
Composite all-or-none measures sum performance across a number of indicators for an 
individual patient, and credit is given only when all of the indicators have been attained. 
Interest in such measures has recently been stimulated by the Institute for Healthcare 
Improvement, the Joint Commission on Accreditation of Healthcare Organizations, and 
the National Committee on Quality Assurance as an approach that offers a more complete 
profile of a patient’s care for a particular condition (Nolan 2006). 
 
The Minnesota health care community has long been recognized as a leader in 
innovative practices for delivery and organization of medical care, so it is not surprising 
that the community’s measurements are innovative as well. Thus, care systems in the 
Twin Cities have been promoting composite all-or-none measures, based on the belief 
that transformational improvement will happen only when a care system assesses more 
than individual process and outcome measures—it instead needs to report on patients 
being up to date on all key indicators. Composite measures appear to accelerate 
improvement in medical groups with team-based initiatives; it is uncomfortable for 
clinicians and health care leaders to see personal performance rates of less than10 percent 
for composite measures, and reaction is commonly vigorous. 
 
Examples of composite measures in the inpatient setting abound, but composite 
measures in the ambulatory area are not yet widespread. Composite measures were not 
feasible before the refinement of the EHR, which now captures key information such as 
aspirin and tobacco use in structured data fields. 
 
How Composite Measures Drive Workflow Change 
Trying to ensure that each patient is up to date for all diabetes care services (hemoglobin 
A1c, LDL, blood pressure, aspirin, no tobacco use) requires an approach different from 
that of trying to change a single measure. When measures are bundled into a composite, 
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 all indicators of the measure need to be addressed simultaneously. No solitary tactic 
(working only on laboratory results, say, or on medications) will work. To move 
performance on composite measures, team collaboration, planning, workflow redesign, 
and system reform are necessary. 
 
Evolution of Diabetes Care Measures 
One-at-a-time measures of diabetes performance initially came from claims-based data, 
which provided dates of service for appointments and tests. 
 
Starting in 2000, Park Nicollet’s Supporting Best Care Department delivered 
quarterly reports to primary care managers and individual clinicians. Results were 
partially blinded, with clinicians seeing only their personal data and comparisons with 
primary care partners at their own clinic site. At that time, Park Nicollet was still 
measuring and reporting individual indicators—A1c, LDL, and urine microalbumin 
values and eye-examination service dates. The phasing-in of the EHR system interrupted 
the production and distribution of these reports from 2003-2005. 
 
In 2004, vital signs and the medication list were reformatted as structured data in 
the EHR, and Park Nicollet was able to add blood pressure, aspirin, and tobacco use to 
the diabetes measure, with the new composite measure being called the “Grand Slam.” 
 
Changes in Primary Care 
Among Park Nicollet’s diabetes patients, primary care clinicians take care of 88 percent, 
most of whom have type 2 diabetes; physicians in the endocrinology departments take 
care of the remaining 12 percent. Park Nicollet’s major improvement efforts began in the 
primary care areas by providing measurement feedback and systems support. 
 
The primary care clinicians’ diabetes performance measures had been improving 
over time, but publishing the diabetes data with the composite measures in a partially 
unblinded fashion across the primary care departments evoked strong reactions from 
clinicians. In response, primary care administrative leaders implemented better support 
processes for standard work—tailoring the visit for each patient the day before and, once 
in the office, getting the patient ready to see the clinician. Now that the basic care processes 
have been established, Park Nicollet’s primary care leaders are directing attention to 
more aggressive drug therapies for glycemic, lipid, and blood pressure control. 
 
Changes in Specialty Care 
After the composite measures were established in the Twin Cities, they were followed by 
aggressive pay-for-performance incentives, which prompted Park Nicollet administrators 
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 to begin working with the endocrinology departments—whose practice and operations 
are very different from those of primary care departments. Endocrinologists serve as 
primary diabetes clinicians for the majority of patients with type 1 diabetes, insulin 
pumps, end-stage renal disease or transplants, and other significant comorbidities. These 
specialists, who have complex issues with management of hypoglycemia, for example, 
argue that it is more difficult for them to achieve the aggressive goals in their patient 
population. Guidelines for glycemic control, they point out, are established for people 
with type 2 diabetes, even though the local and national measurement standards reflect 
the spectrum of diabetes, both type 1 and 2. Park Nicollet clinicians and leaders continue 
to have lively discussions on how to improve intermediate outcomes and set goals in this 
group of patients with difficult management issues. 
 
Park Nicollet Performance Over Time 
Performance on the composite all-or-none measure over time is shown in the figure 
below. The graph distinguishes between sites that have instituted an extended laboratory 
menu (ELM)—the process of obtaining test results from the laboratory immediately 
before the patient’s visit—and those that have not. This process has created timely face-
to-face conversations between the clinician and patient about behavior and drug therapy, 
allowing the clinician to start or change therapy more successfully in the diabetes 
population not yet meeting goals. 
 
Composite Measure Specifications 
• Denominator: Includes all patients in the diabetes registry who are age 18 through  
75 and during the preceding 24 months have been seen at least twice in the 
ambulatory setting with an ICD-9 diagnosis of diabetes. (At the time the registry was 
established, Park Nicollet did not have the capacity for automating medication 
information to use for building the denominator. Also, because the registry was 
established before the EHR problem list, Park Nicollet could not use the list to enroll 
patients in the registry.) 
 
• Individual Numerator Measures 
• % hemoglobin A1c < 7 in the past 12 months 
• % LDL cholesterol < 100 in the past 12 months 
• % blood pressure < 130/80 in the past 12 months 
• % daily aspirin use 
• % not using tobacco 
 
Composite Measure: percentage of patients with A1c, LDL, and BP at goals and up to 
date, who use aspirin daily, and who do not use tobacco (the “Grand Slam”) 
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 Clinician Assignment 
Key to a measure that stimulates quality improvement is the accurate assignment of 
patients to clinicians. Park Nicollet has used different algorithms over time and currently 
uses the following rules: 
 
Type 2 Diabetes 
• Patients treated by Park Nicollet primary care clinicians are assigned to the 
clinician directing the majority of the visits for diabetes for that patient. 
• Patients who are referred for diabetes consultation to the International Diabetes 
Center (for education) or to a Park Nicollet endocrinologist remain within the 
primary care clinician’s panel. 
• Patients who are treated by non-Park Nicollet clinicians for their diabetes care are 
assigned to their non-Park Nicollet primary care clinician and to the Park Nicollet 
diabetes clinician (approximately 500 out of 12,000 patients therefore have two 
assigned clinicians). 
 
Type 1 Diabetes 
• Patients who are treated by a Park Nicollet endocrinologist for diabetes care and 
seen by a Park Nicollet primary care clinician only for non-diabetes visits are 
assigned to the endocrinologist. 
• Type 1 diabetes patients with a non-Park Nicollet primary care clinician and seen 
by a Park Nicollet endocrinologist will be assigned to the endocrinologist if told 
to return to him or her within 12 months. If these patients are returned to their 
non-Park Nicollet clinician with diabetes recommendations, they will be assigned 
to that clinician. 
 
Data Requirements 
• Diabetes measurements are based on standards set by HEDIS. Inclusion in the 
diabetes cohort for an organization is based on a set of qualifying ICD-9 and CPT 
Evaluation and Management codes. 
• A1c test results are obtained from the data warehouse, having been extracted from 
the laboratory files within the EHR application (LastWord). 
• LDL cholesterol test results are obtained from the data warehouse, having been 
extracted from the laboratory files within the EHR application (LastWord). 
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 • Systolic and diastolic blood pressures are obtained from the Flowchart Viewer 
screen of the EHR. (Blood pressure is taken only from clinic readings, not 
hospital readings.) 
• Tobacco use status is obtained from the Flowchart Viewer screen of the EHR. 
(Credit is only given if the patient is a nonsmoker.) 
• Daily aspirin use (any amount) is obtained from the Outpatient Medications 
screen in the EHR. 
 
Adding Laboratory Values that Originate Outside Park Nicollet 
Because Park Nicollet has many patients who have testing done at outside laboratories or 
are participating in research studies that use reference laboratories, a critical validity issue 
for measurement is the documentation of studies done outside the Park Nicollet setting. 
This external testing process pertains especially to patients seen in specialty departments. 
To deal with the potentially missing data, Park Nicollet has added a structured flowsheet 
that captures external sources of laboratory data and can be queried for test results and 
dates of service. 
 
Conclusion 
Many opportunities and challenges developed during the design, building, and 
implementation phases of this composite all-or-none measure. The issues that Park 
Nicollet continues to address for improving performance on the measure include standard 
work for: planning between visits, tailoring the visit for each patient the day before, 
getting the patient ready to see the clinician in the office, organizing the components of 
the clinician visit, assuring that needed information is at hand for prescription changes, 
and having processes in place for follow-up on testing and other outcomes of the visit. 
 
Composite measurement has dramatically altered the approach to quality 
improvement at Park Nicollet. The organization understands that infrastructure and 
teamwork are needed to raise the bar on performance. 
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 CASE STUDY #3 
Warfarin/Antibiotic Rule for the EHR 
 
Billings Clinic 
Billings, Montana 
 
Patricia Coon, M.D. 
 
 
Goal 
The overall goal of this case study is to improve patient safety by reducing adverse drug 
responses—in particular, hemorrhagic events caused by warfarin/antibiotic interactions. 
 
Rationale 
The Warfarin/Antibiotic Rule, an innovative care indicator that takes advantage of the 
unique capabilities of the EHR and related HIT, is designed to improve communication 
between the health care provider who is ordering an antibiotic for a patient on warfarin 
and the pharmacist who is managing the patient’s chronic anticoagulation therapy. A 
number of commonly prescribed antibiotic, antiviral, and antifungal medications have 
significant interactions with warfarin, thereby increasing the risk for bleeding. When 
these medications are ordered, more frequent monitoring of a patient’s prothrombin time 
(INR)—a standardized way of monitoring blood-clotting—is required to avoid adverse 
events. EHR prompting may also reduce risk by altering the antibiotic-prescribing habits 
of health care providers. Choosing an antibiotic that produces little or no interaction with 
warfarin, rather than one with high interaction, minimizes the risk of complications and 
the need for more frequent monitoring. Our organization believes that the rulemaking 
capacity of the EHR provides a viable alternative to existing electronic alerts on drug 
interactions, which frequently cause “alert fatigue.” 
 
Description 
When a provider in our health care system attempts to electronically prescribe a high-risk 
antibiotic and the patient has warfarin listed on his or her medication profile, one of two 
text boxes pops up on the screen: 
 
Text Box Pop-Up for Patients Followed by the Anticoagulation Clinic 
This text box alerts the provider to a potentially moderate- to high-risk drug/drug 
interaction. It also states that if the clinician persists in prescribing this antibiotic, an alert 
will be automatically sent to the pharmacist in the anticoagulation clinic. At this point, 
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 the provider can launch a screen that lists warfarin/antibiotic interactions, ranked in order 
from no risk to high risk, so that he or she may chose a different antibiotic that is equally 
effective but causes little or no warfarin interaction. If the provider indeed prescribes 
such an antibiotic, no alert is “fired.” In the case when such an alert is fired and received, 
the pharmacist electronically documents the action taken, using a drop-down box format. 
 
Requirements for the rule to fire: the patient has warfarin on his or her medication 
profile, the antibiotic ordered has moderate to high interaction with warfarin, and the 
patient is followed by the anticoagulation clinic. 
 
Text Box Pop-Up for Patients Not Followed by the Anticoagulation Clinic 
This text box alerts the provider to a potentially moderate- to high-risk drug/drug 
interaction and encourages him or her to get a prothrombin time/INR measurement of the 
patient in three days if the medication is prescribed. This alert also allows providers to 
launch a screen that lists warfarin/antibiotic interactions, ranked in order from no risk to 
high risk, thereby enabling them to choose a medication with minimal interaction. If an 
antibiotic with moderate to high risk is prescribed, providers have the option to print out a 
patient information sheet that instructs them to call the primary care provider for further 
management. This text box pop-up was developed for use by our rural health care providers 
and urgent care providers, who see patients not followed by our anticoagulation clinic. 
 
Requirements for the rule to fire: the patient has warfarin on his or her medication 
profile, and the antibiotic ordered has moderate to high interaction with warfarin. 
 
Development and Refinement 
To develop the Warfarin/Antibiotic Rule, an ad hoc committee comprising individuals 
from Billings Clinic’s Information Services (IS), Electronic Medical Record Committee, 
and Pharmacy Department was formed. Committee members included a pharmacist from 
the Anticoagulation Clinic, two primary care providers, a primary care office coordinator, 
and the key personnel from IS. Committee members formulated and agreed on the 
parameters for the rule, and IS staff wrote the rule and implemented it into the EHR. The 
rule was then tested for reliability in a nonclinical environment. 
 
In September 2006, the Warfarin/Antibiotic Rule was partially activated in the 
clinical environment. At that time, pharmacists in the Anticoagulation Clinic were alerted 
when any patient on warfarin therapy was placed on a nontopical antibiotic, antiviral, or 
antifungal agent, regardless of the degree of interaction. The clinic received up to 20 such 
alerts daily, which required a significant time commitment and interfered with workflow. 
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 Several primary care providers agreed to pilot the new rule, which had been programmed 
to fire pop-up alerts if they ordered an antibiotic with anywhere from low to severe 
warfarin interaction. 
 
Two months after implementing the Warfarin/Antibiotic Rule, the ad hoc 
committee met with representative individuals piloting the alert. There was consensus on 
three issues: 
 
1) The rule should only fire when an antibiotic, antiviral, or antifungal with a 
moderate to severe warfarin/drug interaction is ordered. No clinical action is 
needed for medications with little or no interaction. This modification would 
significantly reduce the workload for the Anticoagulation Clinic staff. 
2) The Pharmacy Department would prepare a table that rated warfarin and 
antibiotic/antiviral/antifungal interactions as either none, low, moderate, or 
severe. Health care providers who had begun prescribing a high-risk drug could 
launch this table directly from the pop-up box alert in order to search for an 
alternative—i.e., a medication that is equally effective but has little or no 
interaction with warfarin. 
3) Two pop-up alerts were needed—one for patients followed by the 
Anticoagulation Clinic and another for those whose anticoagulation is managed 
by primary care providers. 
 
Primary Outcome Measures 
The effect of the Warfarin/Antibiotic Rule on the following outcome measures will be 
tracked quarterly: 
 
• Percent of elevated INR excursions—i.e., INR > 6—caused by warfarin-antibiotic 
interaction. 
• Number of antibiotic-induced elevated INR excursions per patient followed by the 
Anticoagulation Clinic. 
 
Data Sources 
EHR electronic medication profile; EHR inbox; and Anticoagulation Clinic electronic 
monitoring form—an e-form for all patients followed by the clinic with the patient’s 
name and anticoagulation monitoring information. 
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 Reach 
The rule affects all health care providers in the system who prescribe antibiotics 
electronically in the outpatient setting, which includes the outpatient clinic, urgent 
care clinics, emergency room, and outpatient surgery. The rule will not fire in the 
inpatient setting because pharmacists already check all medications ordered there for 
drug/drug interactions. 
 
Challenges 
• Loss of health care provider autonomy—i.e., the alert is automatically fired to the 
Anticoagulation Clinic once the antibiotic has been e-prescribed. Although this was 
a concern brought up by the ad hoc committee, it has not proven to be an issue. 
• Restructuring of workflow process for pharmacists in Anticoagulation Clinic. 
 
Current Status 
Development of the electronic Warfarin/Antibiotic Rule is now complete. The rule was 
piloted in several primary care provider offices from September 2006 to March 2007. 
Systemwide implementation—that is, the training of all physicians and office nurses with 
access to our EHR—was finished by March 2007. Independent of providers, pharmacists 
in the Anticoagulation Clinic have been receiving alerts on clinic patients since 
September 2006. 
 
Principal Findings 
Since implementation, the alert has been fired an average of 3–4 times a day for a panel 
size of approximately 1,300 patients. The percent of patients with elevated INR excursions 
(INR>6) caused by warfarin-antibiotic interaction has decreased from 0.20 to 0.13. 
Preliminary reports show that the number of antibiotic-induced elevated INR excursions 
per patient followed by the Anticoagulation Clinic has been reduced by about 25 percent. 
 
Clinician Comments 
The pharmacists in the Anticoagulation Clinic believe that this rule will improve patient 
safety throughout the organization. Because the clinic receives about 2–3 alerts per day, 
they do not think the rule appreciably increases daily pharmacy workload or interferes 
with workflow. Pharmacists suggest that it may actually improve workflow by decreasing 
telephone calls from health care providers and patients who are alerting them about the 
start of antibiotic therapy. Pharmacists note that patients are surprised and pleased to 
receive a telephone call from the Anticoagulation Clinic within hours of obtaining the 
antibiotic prescription. 
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 Primary care providers (PCPs) and office nurses who piloted the rule do not 
believe that it increases office workload or interferes with workflow. The providers feel 
that the pop-up boxes are clear and easy to use; and, because the rule fires so infrequently, 
“alert fatigue” from the boxes is not a concern. Providers enthusiastically support use of 
the rule to automatically alert the Anticoagulation Clinic when a moderate- to high-risk 
antibiotic is ordered; loss of PCP autonomy is not perceived to be an issue. Upon seeing 
the pop-up box alert, some PCPs have used the warfarin/antibiotic interaction list to 
choose a different antibiotic that is equally effective but has little or no warfarin interaction. 
The PCPs and office nurses believe that the rule will enhance patient safety. 
 
Conclusions 
Implementation of an EHR-based Warfarin/Antibiotic Rule has a positive effect on 
provider-to-provider communication and may reduce the risk of adverse outcomes— 
e.g., hemorrhagic events caused by warfarin/antibiotic interactions. This rule relies on 
traditional components of an EHR—the electronic medication profile, for example. 
Therefore, it is plausible that other health care organizations with comprehensive EHRs 
might see these systems’ rulemaking capacities as capable of improving communication 
among health care providers and enhancing patient safety. 
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 CASE STUDY #4 
Assessing Clinician Adherence to Smoking-Cessation Guidelines 
Using MediClass: An Innovative Natural-Language Processing Tool 
 
Kaiser Permanente of the Northwest 
Portland, Oregon 
 
Dean F. Sittig, Ph.D., and Brian L. Hazlehurst, Ph.D. 
 
 
 
Introduction 
Many quality measures, such as HEDIS, use smoking-cessation counseling as a key 
indicator of quality of care (Solberg 2003, Chin 1997). There are three main reasons: 
smoking’s status as the leading preventable cause of death in the United States (CDC 
2003, HHS 2004, Mokdad 2004); smoking cessation’s aid in reducing the risk of 
premature death (Wewers 2003); and the fact that direct counseling by the patient’s 
primary care provider is one of the most successful methods of getting patients to stop 
smoking, with a quit rate of up to 10 percent (Prochazka 2000, Cokkinides 2005). Current 
practice is to use patient surveys (by mail or telephone) to measure clinician performance, 
though the results obtained from the two survey methods can be quite different (Solberg 
2003). We believe that medical-record review is a better alternative; it is more accurate 
and reliable and less bothersome to patients. Also, in a large integrated group-practice 
setting, patients are often seen by more than one health care provider. Consequently, it is 
critical that all providers accurately record their findings, advice, actions, and plans in the 
medical record so that the next providers can pick up where they left off. Therefore we 
were interested in developing an EHR-based measure, based solely on the data contained 
in our state-of-the-art electronic medical record system, of how well our clinicians were 
adhering to the smoking-cessation counseling guidelines described below (Chin 1997). 
 
Measuring the 5As of Smoking-Cessation Care 
The nationally recommended treatment model (Dolin 2006) involves five steps, or “the 
5As”: Ask, Advise, Assess, Assist, and Arrange follow-up. Although some of these steps 
are easily coded into the EHR (e.g., identification of smoking status or prescriptions for 
smoking-cessation drugs), others are typically recorded free-text style in the progress 
notes or the patient instruction portions of the medical record. 
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 Below is a table of the 5As, their operational definitions, and an example of free-
text notation in the EHR. 
 
Table 2. The “5As” Recommended by the Current U.S. Public Health Service 
Clinical Practice Guideline for Tobacco Treatment and Prevention 
5A Step Operational Definition 
Example in Free-Text Section 
of EHR 
Ask Identify tobacco-user status at every visit. “Patient smokes 1ppd.” 
Advise Advise all tobacco users to quit. “It is important for you to quit smoking now.” 
Assess Determine the patient’s willingness to make a quit attempt. 
“Patient not interested in 
quitting smoking.” 
Assist Aid the patient in quitting. “Started patient on zyban.” 
Arrange Schedule a follow-up contact, in person or by telephone. “F/u in 2 wks for quit progress.” 
 
Design and Development of MediClass 
The MediClass system was built from open-source and freely available software 
components. It uses three distinct information and communication system technologies: 
 
• The Health Level 7 (HL-7) Clinical Document Architecture (CDA) (Dolin 2006) 
• Natural-language processing (NLP) techniques 
• Knowledge-based systems. 
 
MediClass currently employs a customized version of the CDA that simplifies 
classification processing while permitting compatibility with this emerging standard for 
health record data. 
 
MediClass combines NLP techniques with knowledge-based systems technology. 
Using NLP knowledge modules, MediClass maps the contents of each encounter to a 
controlled set of clinical concepts based on (1) phrases detected in free-text sections and 
(2) codes detected in structured sections of the medical record. This knowledge was 
encoded into the MediClass system as an application-specific “knowledge module.” 
 
Testing of NLP Knowledge Module 
The project requested the electronic health records of about 1,000 known smokers at each 
of four institutions. These EHRs included relevant data from single office visits with 
primary care clinicians. 
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 In preliminary work, 500 records—125 randomly selected from each of the four 
sites—were coded both by trained chart abstractors and MediClass (MC). After 
disagreements (such as misclassifications) between MC and the human raters were 
assessed, MediClass was improved and rerun to validate the revised system. The records 
used in this preliminary work were then removed from the data pool, leaving 875 records 
from each health plan. 
 
Validation of the MediClass System 
Our preliminary work (described above) as well as previous studies showed that several 
of the “As” are infrequently found in the data. Therefore, the validation study used a 
sample of records composed both of random and “enriched” portions (the latter located 
by the MediClass system). Because the final size of the enriched portion of our sample 
was 77 records, the rest of our sample (423 records) was then randomly drawn from the 
remaining data pool, stratified by health plan. Thus the preliminary work’s final sample 
of 500 records contained 125 records from each of the four health plans. 
 
Four trained medical record reviewers coded all 500 records. These abstractors 
were trained to look for evidence of documentation of the 5As of smoking-cessation 
counseling, and they were asked to identify whether each “A” was absent or present  
in each record. The sites anonymously submitted the results of this work to our 
coordinating center. 
 
Results of the Validation 
To analyze these data we created a “gold standard” based on the majority opinion of the 
human raters (i.e., when three or four of the raters agreed on the presence or absence of a 
particular A). We then computed the accuracy of MediClass against this standard. 
 
MediClass agreed with the gold standard 91 percent of the time. Point estimates 
of sensitivity for each of the first four As (the fifth A could not be compared, because of 
the low frequency of its occurrence) were found to be 0.97, 0.68, 0.64, and 1.0, 
respectively. Point estimates of specificity were 0.95, 1.0, 0.96, and 0.82. 
 
Impact of MediClass Use on Physicians 
A clinical trial involving four disparate health plans used MediClass to generate quarterly 
feedback reports to individual doctors. These reports were based on information contained 
both in the free-text and coded sections of electronic health records in routine clinical 
use. A preliminary analysis found improved adherence on some of the key measures of 
smoking-cessation care. A complete report on the trial’s findings is in preparation. 
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 Lessons Learned from MediClass 
Over the course of the clinical trial we learned many important lessons regarding the use 
of NLP tools to analyze both the coded and free-text data contained in EHRs. These 
lessons included the following: 
 
• The practice of medicine is constantly changing, as are the EHRs that clinicians use 
to document their actions. Thus, while many people think that once an EHR is 
installed you are “home free,” it turns out that changes in the EHR infrastructure, or 
the entire EHR, are not uncommon (Campbell 2006). In fact, two of the health plans 
replaced their EHRs during the four-year study period. 
• The NLP solution was more consistent than the human chart abstractors, although this 
solution has both pluses and minuses. For example, the NLP solution never gets tired 
reading the notes, and never varies in it's interpretations of the data. Human coders on 
the other hand continue to make new and different errors over time, and can exhibit 
significant variability among coders. 
• As clinicians become more acclimated and knowledgeable about using EHRs, they 
may begin recording less and less information in the free-text portions of the record. 
We expect they may record less because they feel that the coded data from the 
clinical laboratory and their orders adequately document their findings and actions. 
Unfortunately, secondary reviewers of the chart, be they other clinicians, or medical 
chart abstractors, can not always determine the original clinician's interpretation of 
the data or their motivation behind the resulting orders. 
• The use of “automatic,” or “canned,” phrases can wreak havoc on an NLP system and 
challenge our ability to interpret the text, whether by machine or by humans. 
Specifically, this machine-generated text is "not natural" and is often formatted and 
expressed differently and in much greater volume than routine, human-generated text. 
On the other hand, if the same "canned text" phrases are used repeatedly, the NLP 
solution can be trained to understand these phrases very easily. 
• Clinicians use EHRs in an ad hoc manner. In other words, different clinicians use 
diverse system features in many different ways. This variation leads to the 
information being recorded in many different ways and in many different physical 
locations within the record. The fact that both humans and NLP solutions need to 
look for this information in these disparate locations makes it difficult to interpret the 
meaning of information entered into the system. 
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 Future Enhancements and Plans for MediClass 
Since we developed the knowledge modules required to identify smoking-cessation 
counseling behaviors, we have created several more knowledge modules capable of: 
 
• Finding evidence of adverse reactions to vaccinations (Hazlehurst 2005); 
• Identifying clinical classifications of diabetic retinopathy that are not supported 
by regular ICD-9 coding schemes (Smith 2005); and 
• Identifying patients with a family history of cancer (Hazlehurst). 
 
Conclusion 
Informative and essential data within the free-text portion of clinicians’ notes and other 
text portions of the EHR are unavailable to most methods of automated health care 
assessment. Because of the clinical value of the EHR narrative, and the poor acceptance 
thus far of structured data entry, one might therefore think it unlikely that wholesale 
replacement of the narrative with structured data entry will succeed. But MediClass 
demonstrates the feasibility of an automated coding system for processing the entire 
EHR, enabling assessment of smoking-cessation care delivery. Such a system can be 
similar in accuracy to that of trained human coders. Systems like MediClass can help 
bridge the gap between the promise and the realization of EHRs’ value. 
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 CASE STUDY #5 
Problem List Diagnosis Reconciliation 
 
Geisinger Health System 
Danville, Pennsylvania 
 
Mark Selna, M.D. 
 
 
The Problem to Overcome, the Opportunity to Realize 
If information on diagnoses, conditions, or risk factors does not exist in the patient’s 
EHR, does not exist in any other structured and unambiguous context, or is inconsistent 
within the record itself, its utility with regard to effective decision support is limited—
that is, the information is not accurate, current, or readily available. 
 
The diagnoses with the greatest validity continue to be those that the treating 
provider has actively added to the patient’s “Problem List.” But, because the documentation 
workflow inherent in most EHRs does not require reconciliation of encounter diagnoses 
with those on the patient’s Problem List, and because EHR Problem Lists are usually not 
as visually evident as those within paper medical records, most EHR data sets are prone 
to having incomplete Problem Lists as well as significant discrepancies between the 
patients’ encounter diagnoses and their Problem List diagnoses. 
 
For resource-intensive or high-morbidity clinical care processes, such as disease-
specific case management programs, the targeting specificity that can be achieved with a 
high-integrity Problem List is invaluable. Thus, to assess the integrity of the Problem List 
diagnoses—both with regard to accuracy as well as internal consistency (i.e., relative to 
other representations, such as encounter diagnoses, in the record)—quantitative 
performance measures are required. 
 
Indicator Description 
The percentage of patients with selected “high-impact” chronic-disease diagnoses, based on 
ambulatory encounters with providers, that have such diagnoses on their “Problem List.” 
 
Indicator Specifications 
The eligible population comprises patients who must: 
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 1) Have had at least two completed ambulatory encounters with a Geisinger Health 
System (GHS) Primary Care Provider (PCP) within the prior 24 months 
2) Have at least one of the high-impact chronic diseases associated with their 
completed ambulatory PCP encounters or active on their Problem List. 
 
Denominator: The combined count of all unique (patient-level) high-impact ambulatory 
encounter diagnoses from the prior 24 months. 
 
Numerator: The combined count of all unique (patient-level) high-impact ambulatory 
encounter diagnoses that have the corresponding high-impact diagnosis active on the 
patient’s Problem List. 
 
Required Data (for each eligible patient) 
• Current PCP designation (Geisinger or non-Geisinger) 
• Ambulatory encounter diagnoses from the prior 24 months (PCP and 
non-PCP encounters) 
• Current Problem List diagnoses. 
 
Required Data Sources (EpicCare) 
• Table: Patient (Field: Current PCP Provider ID) 
• Table: Patient Encounter Diagnosis (Field: ICD-9 Code) 
• Table: Problem List (Fields: ICD-9, Status) 
 
Supplemental Information 
• Table: Provider Master File (Fields: Provider ID, Employment Status) 
• Table: High-Impact diagnoses (descriptions, ICD codes) 
 
Indicator Development 
The primary challenges in developing this indicator were the many arbitrary decisions 
required in defining the specifications. For example, high-impact chronic-disease 
diagnoses were primarily chosen in accordance with their population-wide prevalence or 
medical expenses, as opposed to their patient-specific burdens. 
 
Another common challenge was deciding which disease-specific ICD code sets 
would yield the most accurately diagnosed target population—the methodological bias was 
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 to favor third-party specifications (e.g., CMS Physician Group Practice Demonstration; 
applicable HEDIS specifications). Lastly, in order to better ensure that the population 
profiled by the indicator was one that was receiving ongoing management by the 
Geisinger Health System (i.e., at least one follow-up opportunity for the PCP to 
“reconcile” the Problem List), only patients who had had at least two completed 
ambulatory encounters with a Geisinger PCP within the prior 24 months were included. 
(Patients who expired during the reporting period were not excluded.) 
 
The high-impact chronic-disease diagnoses chosen were congestive heart failure 
(CHF), chronic obstructive pulmonary disease (COPD), diabetes, depression, coronary 
artery disease (CAD), and hypertension (HTN). 
 
Indicator Evaluation 
Using the specifications described above, independent diagnosis-specific populations 
(denominators) were identified. Each population was then stratified according to two 
variables: (1) the presence or absence of that diagnosis on the patient’s Problem List; and 
(2) the number of high-impact disease-specific PCP ambulatory encounters. (Note that 
many patients had multiple high-impact chronic-disease diagnoses and, as such, were 
included in several independent denominator populations.) 
 
As shown in the attached table, the indicator revealed that the proportion of 
target-population patients with the required ICD code on the Problem List varied from a 
high of 89 percent to a low of 59 percent, depending on the high-impact chronic-disease 
diagnosis. However, it is not clear from this case study how much the ambulatory 
visit frequency threshold or the length of the performance period affected the utility of 
the indicator. 
 
Indicator Feasibility and Generalizability 
Because this indicator relies only on traditionally codified data (i.e., ICD codes), it is 
feasible to administer. The primary caveat is with regard to a provider’s encounter-based 
Problem List coding practices. Specifically, unless the Problem List diagnoses, as with 
the encounter diagnoses used to generate a billing claim, are represented by (or linked to) 
specific structured diagnosis data, reliable reproducible correlations are not possible. 
 
For this indicator to be generalizable, it would need to support a provider’s 
clinical-management or business objectives. For example, given the recent expansion of 
diagnosis-based quality reporting prompted by “pay-for-performance” initiatives, some 
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 providers might rely more heavily on their Problem Lists to develop disease-specific 
registries and tracking programs. 
 
The operational questions raised by this indicator involved the potential use of 
less manual means of populating the Problem Lists. Specifically, one could ask providers 
to consider whether any of the following three options were clinically appropriate and 
acceptable to them: (1) auto-populate the Problem List with every high-impact chronic-
disease ambulatory encounter diagnosis; (2) impose a “hard-stop” alert that presents at 
the time of encounter-diagnosis coding to notify the provider of an opt-out “auto-
population” of the Problem List; or (3) require providers to retrospectively review and 
reconcile lists of their patients whose high-impact chronic-disease encounter diagnoses 
do not appear on their Problem Lists. 
 
This measure has served as the impetus to engage in additional analyses and 
“clean-up” work (such as eliminating duplicate diagnoses, eliminating or explicitly 
mapping standard diagnosis codes, or resolving mutually exclusive diagnoses). 
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 FIVE CASE STUDIES: CONCLUSIONS 
 
 
In Park Nicollet’s composite measure that spanned the range of diabetes care, in 
Billings Clinic’s warfarin/antibiotic alert, and in the other case studies, it was striking 
how performance measures became much more clinically relevant when they were 
HIT-based. 
 
But major barriers in these e-indicators’ conceptualization and development, such 
as the validity of data extracted from the EHR, became apparent as well. Many of the 
case studies noted the challenge of correctly defining a specific patient population—a 
critical prerequisite to accurate assessment—using ICD-9 classification codes; and two 
studies (Park Nicollet and HealthPartners) highlighted issues involving incorporation of 
data from patient-related actions (e.g., procedures, visits, or referrals) that occurred 
outside the EHR system. 
 
Most case studies implemented workable solutions to these validity concerns. For 
example, providers used manual chart-review comparisons, more specific diagnostic 
codes (such as SNOMED), and specialized structured flow sheets to integrate outside 
data. These methods helped to promote standardized and comprehensive patient coding, 
which is critical to any EHR-derived quality measure. 
 
Another major barrier was the reliability of the EHR-extracted data, which may 
not be collected and recorded consistently across the patient population. Many case 
studies pointed out the difficulty of coding data about patients, diagnoses, and procedures 
in any uniform way; it can be challenging just to record information consistently within 
one patient’s EHR. 
 
Two of the case studies addressed concerns with standardization through opposite 
data-collection strategies. Geisinger examined the reliability of using a patient’s Problem 
List to automatically identify “high-impact” cardiovascular patients. This case study 
suggested the possibility of implementing algorithms to ensure that patients are not 
incorrectly excluded from quality measures. Kaiser, on the other hand, examined the 
potential of using free-text language-recognition software to translate physicians’ notes 
into the equivalent of structured data fields. 
 
Prior to their implementation, providers expressed concern that the measures 
would hinder workflow or suffer from staff resistance. In actuality, few such events 
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 occurred. On the contrary, the case studies indicated that EHR systems improved 
workflow by automating key communications between staff and by improving patient-
record accessibility across different clinics. Even where staff initially resisted the new 
systems, additional staff-support infrastructure and departmental leadership dramatically 
increased both measure compliance and overall performance. 
 
Measures that translated established quality indicators had the easiest transition 
into EHR. These measures usually had clearly defined specifications, after all, and in 
many cases the corresponding data were already being compiled through manual chart 
reviews. Consequently, the measures readily lent themselves to comparisons against 
past performance, particularly on dimensions such as cost savings, compliance, and 
provider quality. 
 
Measures incorporating or evaluating HIT-specific features, such as automated 
alerts and free-text analysis, tended to be more specialized and not as easily incorporated 
into other systems. Nonetheless, most of the providers were confident that the concepts 
could be adapted to different EHR system types. Additionally, specific actions were taken 
to standardize specifications as much as possible, made easier by the fact that populations 
were increasingly being defined through standard coding methods. Thus many patient-
specific data elements necessary to calculate an indicator were likely to be accessible in 
other systems—though a high degree of technical skill would be needed to implement, 
maintain, and evaluate indicators incorporating HIT-specific features. 
 
All of the problems that the case-study measures assessed are amenable to 
performance improvement, and this improvement is made possible by the EHR. Even in 
the Geisinger example, one can “force” concordance between the Problem List and 
provider-encounter diagnoses through changes to the EHR. 
 
The success of the case studies’ providers in implementing EHR-based quality 
measures demonstrates that such measures are worth pursuing, despite the challenges of 
ensuring the validity and reliability of data, efficient workflow, and staff support. The 
cases illuminate the paths that need to be followed to move effectively into 21st-century 
quality measurement. Although using established indicators can facilitate such a 
transition, deploying and measuring HIT-specific features offers valuable benefits that 
highlight EHRs’ unique contributions to quality. 
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